Attention BIOA Investors: Don’t Miss Your Chance to Lead the Fight for Justice with Robbins Geller Rudman & Dowd LLP!
SAN DIEGO, Jan. 14, 2025 (GLOBE NEWSWIRE)
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of BioAge Labs, Inc. (NASDAQ: BIOA) stock pursuant and/or traceable to BioAge Labs’ registration statement issued in connection with BioAge Labs’ initial public offering (“IPO”) held on September 26, 2024, have until March 10, 2025 to seek appointment as lead plaintiff of the BioAge Labs class action lawsuit.
Captioned Soto v. BioAge Labs, Inc., No. 25-cv-00196 (N.D. Cal.), the BioAge Labs class action lawsuit charges BioAge Labs as well as certain of BioAge Labs’ top executives and directors with violations of the Securities Act of 1933.
Investors, Take Action Now!
If you are an investor in BioAge Labs, Inc. and believe that you have been misled or harmed by the actions of the company’s executives and directors, now is your chance to seek justice. By joining the class action lawsuit as the lead plaintiff, you can help hold the responsible parties accountable for their actions.
Robbins Geller Rudman & Dowd LLP is a prestigious law firm with a proven track record of successfully representing investors in securities litigation. With their expertise and dedication to fighting for justice, you can trust that your case will be in good hands.
Don’t wait until it’s too late. Contact Robbins Geller Rudman & Dowd LLP today to discuss your options and take the first step towards seeking the compensation you deserve.
—
How Will This Affect Me?
If you are an investor in BioAge Labs, Inc., this class action lawsuit could have a significant impact on your financial interests. By seeking appointment as the lead plaintiff, you have the opportunity to potentially recover damages for any losses you may have incurred as a result of the alleged securities violations.
It is important to take action now and consult with legal counsel to understand your rights and options in this matter. By participating in the lawsuit, you may be able to recoup some of your losses and hold the responsible parties accountable for their actions.
—
How Will This Affect the World?
Class action lawsuits against companies and their executives for securities violations serve an important role in upholding transparency and accountability in the financial markets. By holding companies accountable for their actions, investors can have more confidence in the integrity of the companies in which they invest.
Furthermore, successful lawsuits can set a precedent for ethical business practices and deter future misconduct in the industry. This can lead to a more fair and just financial system that benefits not only investors but also the economy as a whole.
—
Conclusion
Investors in BioAge Labs, Inc. have a unique opportunity to seek justice and potentially recover damages through the class action lawsuit led by Robbins Geller Rudman & Dowd LLP. By taking action now, investors can hold the company’s executives and directors accountable for alleged securities violations and contribute to a more transparent and ethical financial market.
Do not miss your chance to lead the fight for justice. Contact Robbins Geller Rudman & Dowd LLP today to learn more about how you can get involved in the lawsuit and protect your financial interests.
